Pteropus vampyrus (large flying fox): 105294710
Help
Entry
105294710 CDS
T07815
Symbol
CASP3
Name
(RefSeq) caspase-3
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
pvp
Pteropus vampyrus (large flying fox)
Pathway
pvp01524
Platinum drug resistance
pvp04010
MAPK signaling pathway
pvp04115
p53 signaling pathway
pvp04148
Efferocytosis
pvp04210
Apoptosis
pvp04215
Apoptosis - multiple species
pvp04623
Cytosolic DNA-sensing pathway
pvp04650
Natural killer cell mediated cytotoxicity
pvp04657
IL-17 signaling pathway
pvp04668
TNF signaling pathway
pvp04726
Serotonergic synapse
pvp04932
Non-alcoholic fatty liver disease
pvp04933
AGE-RAGE signaling pathway in diabetic complications
pvp04936
Alcoholic liver disease
pvp05010
Alzheimer disease
pvp05012
Parkinson disease
pvp05014
Amyotrophic lateral sclerosis
pvp05016
Huntington disease
pvp05020
Prion disease
pvp05022
Pathways of neurodegeneration - multiple diseases
pvp05132
Salmonella infection
pvp05133
Pertussis
pvp05134
Legionellosis
pvp05145
Toxoplasmosis
pvp05146
Amoebiasis
pvp05152
Tuberculosis
pvp05160
Hepatitis C
pvp05161
Hepatitis B
pvp05162
Measles
pvp05163
Human cytomegalovirus infection
pvp05164
Influenza A
pvp05165
Human papillomavirus infection
pvp05167
Kaposi sarcoma-associated herpesvirus infection
pvp05168
Herpes simplex virus 1 infection
pvp05169
Epstein-Barr virus infection
pvp05170
Human immunodeficiency virus 1 infection
pvp05200
Pathways in cancer
pvp05203
Viral carcinogenesis
pvp05205
Proteoglycans in cancer
pvp05206
MicroRNAs in cancer
pvp05210
Colorectal cancer
pvp05222
Small cell lung cancer
pvp05416
Viral myocarditis
pvp05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
pvp00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
105294710 (CASP3)
04668 TNF signaling pathway
105294710 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
105294710 (CASP3)
09143 Cell growth and death
04210 Apoptosis
105294710 (CASP3)
04215 Apoptosis - multiple species
105294710 (CASP3)
04115 p53 signaling pathway
105294710 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
105294710 (CASP3)
04650 Natural killer cell mediated cytotoxicity
105294710 (CASP3)
04657 IL-17 signaling pathway
105294710 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
105294710 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
105294710 (CASP3)
05206 MicroRNAs in cancer
105294710 (CASP3)
05205 Proteoglycans in cancer
105294710 (CASP3)
05203 Viral carcinogenesis
105294710 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
105294710 (CASP3)
05222 Small cell lung cancer
105294710 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
105294710 (CASP3)
05161 Hepatitis B
105294710 (CASP3)
05160 Hepatitis C
105294710 (CASP3)
05164 Influenza A
105294710 (CASP3)
05162 Measles
105294710 (CASP3)
05168 Herpes simplex virus 1 infection
105294710 (CASP3)
05163 Human cytomegalovirus infection
105294710 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
105294710 (CASP3)
05169 Epstein-Barr virus infection
105294710 (CASP3)
05165 Human papillomavirus infection
105294710 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
105294710 (CASP3)
05133 Pertussis
105294710 (CASP3)
05134 Legionellosis
105294710 (CASP3)
05152 Tuberculosis
105294710 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
105294710 (CASP3)
05145 Toxoplasmosis
105294710 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
105294710 (CASP3)
05012 Parkinson disease
105294710 (CASP3)
05014 Amyotrophic lateral sclerosis
105294710 (CASP3)
05016 Huntington disease
105294710 (CASP3)
05020 Prion disease
105294710 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
105294710 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
105294710 (CASP3)
05416 Viral myocarditis
105294710 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
105294710 (CASP3)
04932 Non-alcoholic fatty liver disease
105294710 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
105294710 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
105294710 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
pvp01002
]
105294710 (CASP3)
Enzymes [BR:
pvp01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
105294710 (CASP3)
Peptidases and inhibitors [BR:
pvp01002
]
Cysteine peptidases
Family C14: caspase family
105294710 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
105294710
NCBI-ProteinID:
XP_011362327
UniProt:
A0A6P3QFQ7
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MENIKNSVDSKSIKNSETKILHGSKSMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTG
MASRSGTDVDAANLRETFTRLNYEVRNSNDLTREEIVELMCSVSKEDHSKRSSFICVILS
HGDEGIIFGTNGPVDLRKLTSFFRGDYCRSLTGKPKLFIIQACRGSELDCGIETDSGVED
DMTCQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKLHADKLELMHILTRVN
RKVATEFESFSFDSTFHAKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacattaaaaactcagtggattcaaaatccattaaaaattcagaaacaaagatt
ttacatggaagcaaatcaatggactctggaatatccttggacaatagttacaaaatggat
tatcctgaaatgggtttatgtataataatcaataataagaactttcataaaagtactgga
atggcatctcggtctggtacagatgtagatgcagcaaatctcagggaaacattcacacgc
ttgaattatgaagtcaggaatagcaatgatcttacacgcgaagaaattgtggaattgatg
tgcagtgtttctaaagaagatcatagcaaaaggagcagttttatttgtgtgattctaagc
cacggtgatgaaggaatcatttttggaacaaatgggcctgttgacctgagaaaattaaca
agttttttcagaggggattattgtagaagtctaactggaaaacccaaacttttcattatt
caggcctgccgaggttcagagctggactgtggtattgagactgacagtggtgttgaagat
gacatgacgtgtcagaaaataccagttgaagcagacttcctgtatgcgtactctacagca
cctggttactattcctggcgaaattccaaggatggatcctggttcatccagtcactttgt
gctatgctgaaactgcacgctgacaagcttgagcttatgcacattcttactcgagttaac
cgaaaggtagcaacagaatttgagtcattttcctttgactctacttttcatgcaaagaaa
cagattccatgtattgtgtctatgctcacaaaagaactgtatttttatcactaa
DBGET
integrated database retrieval system